Human cytomegalovirus DNAemia and preemptive treatment of CMV infection in children after hematopoietic stem-cell transplantation: is any question settled?
Cesaro
Simone
S
Abate
Davide
D
Mengoli
Carlo
C
D000998:Antiviral Agents / Q000494:pharmacology; D002648:Child; D003587:Cytomegalovirus / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology; D003586:Cytomegalovirus Infections / Q000209:etiology* / Q000628:therapy* / Q000821:virology; D004279:DNA, Viral / Q000032:analysis / Q000235:genetics*; D006086:Graft vs Host Disease / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D010750:Phosphoproteins / Q000378:metabolism; D016133:Polymerase Chain Reaction; D016032:Randomized Controlled Trials as Topic; D014763:Viral Matrix Proteins / Q000378:metabolism; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D004279:DNA, Viral; D010750:Phosphoproteins; D014763:Viral Matrix Proteins; C065418:cytomegalovirus matrix protein 65kDa